Jenny Craig is reportedly shutting down some of its weight-loss centers and warning employees of mass layoffs amid upheaval in the industry from popular new prescription drugs like Ozempic
Jenny Craig alerted employees to potential layoffs as it begins “winding down physical operations” and hunts for a buyer, according to NBC News. Jenny Craig has nearly 500 weight-loss centers in the United States and Canada. The company, founded in 1983, did not disclose to CNN how many weight loss centers will close or how many employees will be impacted.
It’s the latest sign of major changes in the weight-loss industry, brought on by popular new prescription diabetes drugs such as Wegovy, Ozempic, and Rybelsus. These relatively new drugs work by stimulating the release of insulin, which helps lower blood sugar. They also slow the passage of food through the gut. The FDA approved Ozempic for the management of diabetes in 2017 and Wegovy for weight loss in 2021. Traditional weight-loss companies are scrambling to adjust.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Jenny Craig warns staffers of mass layoffs as it prepares to shutter locations: reportJenny Craig appears to be shedding more than pounds as it warned employees of potential mass layoffs.
Read more »
Weight loss brand Jenny Craig considers bankruptcyCalifornia-based Jenny Craig Inc., the weight-loss services provider backed by H.I.G. Capital, is considering a bankruptcy filing if efforts to find a buyer for its assets fail.
Read more »
Jenny Craig plans to close its weight-loss centers, report saysEmployees are losing their jobs as weight-loss company's plans to wind down its brick-and-mortar business.
Read more »
FIRST ON CNN: CDC set to stop tracking community levels for Covid-19 | CNNAs the nation's public health emergency expires on May 11, the United States Centers for Disease Control and Prevention will stop reporting its color-coded Covid-19 Community Levels as a way to track the spread of the infection.
Read more »
New weight loss drug on fast-track to rival Ozempic, WegovyDrugmaker Eli Lilly said it's seeking FDA approval of its drug Mounjaro to treat weight loss after late-stage trials showed unprecedented results.
Read more »
New $50 billion weight loss drug could rival OzempicA study found that tirzepatide delivered weight loss results of up to 15.7 percent of a patient's body weight, an average of more than 34 pounds.
Read more »